Security needs to look back"
Release time:
2023-06-25
once watched a safety work meeting of a project department of China Railway Fourth Bureau. There was no lengthy "reasoning". Some were "looking back" on a safety accident that shocked the whole country in 2008-the collapse accident of Xiaoshan Fengqing Avenue subway project ". Starting from 2008, China Railway No.4 Bureau has designated November when the accident occurred as the company's safety production month, and November 15 when the accident occurred as the annual safety study day. All project departments are required to take a safety oath on that day, so as to carry out more in-depth study and "look back" of various accidents, fully analyze the cause and effect of the accident and make slides, play and learn in the group and all project departments. This kind of cognition and handling ability of accidents, not concealing the mentality of daring to face, and often "looking back" to maintain vigilance, the author was deeply touched.
Adhering to the long-term "looking back" of safety production, we can not only better see the good practices and experiences in safety management yesterday or for a longer period of time, but also find the existing drawbacks, deficiencies and various problems. We can master and accumulate more knowledge, experience and lessons of safety work, put an end to the defects and loopholes in safety management, and ensure that the safety work is better and better. Returning to ourselves, have we "looked back" on our safety work?
We should think deeply about why some units have frequent accidents, and some units have not had any safety accidents for several years, more than ten years or longer? Of course, the gap is in management! The more serious situation is that some units found that the safety problem can not be treated correctly, seriously to learn lessons, a good review and summary, to find out the root causes of the accident, management loopholes, system defects, resulting in the presence of safety accidents. Only by conscientiously summarizing and reviewing yesterday can we plug the loopholes in today's safety management, and safety accidents can be completely eliminated.
often "looks back" on safety work. First of all, you can avoid boring safety concepts and use the vivid cases around you to analyze and summarize more profound and unforgettable. The second is to comprehensively review and sort out the shortcomings in the safety management in the past. Is it management, or the system and measures are not sound, or the on-site detail monitoring is not in place? In which areas need to be improved? So as to promote the comprehensive development of safety management in the future. Third, we can compare our own safety management work with the units that have done well, find out the gaps, find out the problems and see the deficiencies. At the same time, it is also a further in-depth, re-study, re-examination, re-review and re-rectification of the safety management work, further recognize the importance of safety work, and grasp the safety work in the future better and more detailed. Fourth, it can not only improve the quality and sense of responsibility of safety management workers, but also enhance the awareness of all employees of safety work, prevention awareness, self-protection awareness, so as to ensure the comprehensive and in-depth safety management work. The lesson of
blood reminds us that safety management must not tolerate the slightest falsehood, the slightest fluke, and must not muddle along. It is necessary to be careful, always cautious, and implement everything, and ensure that safety production runs through all aspects and the whole process. Any mistakes in any link will lead to the imbalance of the whole "safety chain. This shows that it is worth advocating to look back on safety work and should be adhered to for a long time. (No trace)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page